Skip to main content
SpringerLink
Log in

Epidemiology of Acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hoedl S. The disease of Akhnaton. Int J Dermatol 1989;28: 201–203.

    Google Scholar 

  2. Medvei VC. The History of Clinical Endocrinology. New York: Parthenon Publishing Group Ltd, 1993.

    Google Scholar 

  3. Fahlbusch R, Honegger J, Scholt W, Buchfelder M. Results of surgery in acromegaly. In Wass JAH, ed. Treating Acromegaly. Bristol: Journal of Endocrinology Ltd, 1994: 49–53.

    Google Scholar 

  4. Laws ER. Results of trans-sphenoidal microsurgical man-agement of acromegaly. In Wass JAH, ed. Treating Acromegaly. Bristol: Journal of Endocrinology Ltd, 1994: 59–63.

    Google Scholar 

  5. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 1994;41:95–102.

    Google Scholar 

  6. Etxabe J, Gaztambide S, Latorre P, Vazquez JA. Acromegaly: An epidemiological study. J Endocrinol Invest 1993;16:181–187.

    Google Scholar 

  7. Serri O, Robert F, Comtois R, Jilwan N, Beauregard H, Hardy J, Somma M. Distinctive features of prolactin secre-tion in acromegalic patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1987;17:429–436.

    Google Scholar 

  8. Nabarro, JDN. Acromegaly. Clin Endocrinol (Oxf) 1987; 26:481–512.

    Google Scholar 

  9. Zimmerman D, Young WF, Ebersold MJ, Scheithauer BW, Kovacs K, Horvath E, Whitaker MD, Eberhardt NL, Downs TR, Frohman LA. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 1993;76:216–222.

    Google Scholar 

  10. Espiner EA, Carter TAH, Abbott GD, Wrightson P. Pitui-tary gigantism in a 31 month old girl: Endocrine studies and successful response to hypophysectomy. J Endocrinol Invest 1981;4:445–450.

    Google Scholar 

  11. Puchner MJ, Knappe UJ, Ludecke DK. Pituitary surgery in elderly patients with acromegaly. Neurosurgery 1995;36: 677–683.

    Google Scholar 

  12. Jaffe LS, Rosen HN. Normal insulin-like growth factor-I in an elderly woman with acromegaly and medical illness. Arch Intern Med 1994;154:1533–1535.

    Google Scholar 

  13. Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W. The “incidentaloma” of the pituitary gland: Is neurosurgery required? JAMA 1990;263:2772–2776.

    Google Scholar 

  14. Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995;155:181–183.

    Google Scholar 

  15. Famuyiwa OO, Bella AF, Akinlade KS. Acromegaly in Ibadan-A report of six cases. West Afr J Med 1990;9: 232–238.

    Google Scholar 

  16. Jialal I, Reddi K, Omar MA, Van Dellen JR, Joubert SM. Pituitary tumours in African and Indian patients. Trop Geogr Med 1986;38:175–179.

    Google Scholar 

  17. Seino Y, Imura H. Endocrine disorders and diabetes in Japan. Diabetes Res Clin Pract 1994;24:S129-S133.

    Google Scholar 

  18. Wright AD, Hill DM, Lowy C, Fraser, TR. Mortality in acromegaly. Q J Med1970;34:1–16.

    Google Scholar 

  19. Landin-Wilhelmsen K, Tengborn L, Wilhelmsen L, Bengtsson BA. Elevated fibrinogen levels decrease following treatment of acromegaly. Clin Endocrinol (Oxf) 1997;46:69–74.

    Google Scholar 

  20. Siafakas NM, Sigalas J, Filaditaki B, Tsirogiannis K. Small airway function in acromegaly. Bull Eur Physiopathol Resp 1987;23:329–334.

    Google Scholar 

  21. Pekkarinen T, Partinen M, Pelkonen R, Ilvanainen M. Sleep apnoea and daytime sleepiness in acromegaly: Relationship to endocrinological factors. Clin Endocrinol (Oxf) 1987;27: 649–654.

    Google Scholar 

  22. Barkan A. Acromegalic arthropathy and sleep apnoea. J Endocrinol 1997;155:S41–44.

    Google Scholar 

  23. Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, Bonelli M, Lancranjan I, Pagani G. Cholelithiasis and acromegaly: Therapeutic strategies. Clin Endocri-nol (Oxf) 1994;40:401–406.

    Google Scholar 

  24. Schmidt K, Leuschner M, Harris AG, Althoff PH, Jacobi V, Jungmann E, Schumm-Draeger PM, Rau H, Braulke C, Usadel KH. Gallstones in acromegalic patients undergoing different treatment regimens. Clin Invest 1992;70:556–559.

    Google Scholar 

  25. Anderson JV, Catnach S, Lowe DG, Fairclough PD, Besser GM, Wass JA. Prevalence of gastritis in patients with acromegaly: Untreated and during treatment with oc-treotide. Clin Endocrinol (Oxf) 1992;37:227–232.

    Google Scholar 

  26. Cheung NW, Boyages SC. The thyroid gland in acromegaly: An ultrasonographic study. Clin Endocrinol (Oxf) 1997; 46:545–549.

    Google Scholar 

  27. Colao A, Marzullo P, Ferone D, Spiezia S, Cerbone G, Marino V, DiSarno A, Merola B, Lombardi G. Prostatic hyperplasia: An unknown feature of acromegaly. J Clin Endocrinol Metab 1998;83:775–779.

    Google Scholar 

  28. Ballard HS, Frame B, Hartsock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 1964;43: 481–516.

    Google Scholar 

  29. Halse J, Haugen HN. Calcium and phosphate metabolism in acromegaly. Acta Endocrinol (Copenh) 1980;94:459–467.

    Google Scholar 

  30. Lieberman SA, Hoffman AR. Sequelae to acromegaly: Re-versibility with treatment of the primary disease. Horm Metab Res 1990;22:313–318.

    Google Scholar 

  31. Gordon DA, Hill FM, Ezrin C. Acromegaly: A review of 100 cases. Canadian Med Assoc J 1962;87:1106–1109.

    Google Scholar 

  32. Hofeldt FD, Levin SR, Schneider V, Becker N, Forsham P. Clinical features of acromegaly and response to cryohypophysectomy. Rocky Mountain Med J 1973;70:21–24.

    Google Scholar 

  33. Tyrell JB, Wilson CB. Pituitary syndromes. In Friesen SR, ed. Surgical Endocrinology Clinical Syndromes. Philadelphia, JB Lippincott: 1978;304–324.

    Google Scholar 

  34. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. New Engl J Med 1979;301:1138–1142.

    Google Scholar 

  35. Klijn JGM, Lamberts SWJ, De Jong FH, van Dongen KJ, Birkenhager JC. Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. Acta Endocrinol (Copenh) 1980;95:289–297.

    Google Scholar 

  36. Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF. The acromegaly syndrome: Relation between clinical features, growth hormone values and radio-logical characteristics of the pituitary tumours. Q J Med 1982;51:189–204.

    Google Scholar 

  37. Karlberg BE, Ottoson A. Acromegaly and hypertension: role of the renin-angiotensin-aldosterone system. Acta Endocrinol (Copenh) 1982;100:581–587.

    Google Scholar 

  38. Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM, Malarkey WB, Jackson I, Vance ML, Thorner MO, Barkan A, Frohman LA, Melmed S. Octreotide treatment of acromegaly: A randomized, multicenter study. Ann Intern Med 1992;117:711–718.

    Google Scholar 

  39. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med1993;86: 293–299.

    Google Scholar 

  40. Kraatz C, Benker G, Weber F, Ludecke D, Hirche H, Reinwein D. Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system. Klin Wochenschr 1990;68:583–587.

    Google Scholar 

  41. Imai Y, Abe K, Munakata M, Sakuma H, Hashimoto J, Imai K, Sekino H, Yoshinaga K. Does ambulatory blood pressure monitoring improve the diagnosis of secondary hypertension? J Hypertens 1990;8:S71-S75.

    Google Scholar 

  42. Ohtsuka H, Komiya I, Aizawa T, Yamada T. Hypertension in acromegaly: Hereditary hypertensive factor produces hy-pertension by enhancing IGF-I production. Endocr J 1995; 42:781–787.

    Google Scholar 

  43. Terzolo M, Avonto L, Matrella C, Pozzi R, Luceri S, Borretta G, Pecchio F, Ugliengo G, Magro GP, Reimondo G, Uslenghi E, Greco-Lucchina P, Angeli A. Doppler echocardiographic patterns in patients with acromegaly. J Endocrinol Invest 1995;18:613–620.

    Google Scholar 

  44. Williams RA, Jacobs HS, Kurtz AB, Millar JG, Oakley NW, Spathis GS, Sulway MJ, Nabarro JD. The treatment of acromegaly with special reference to trans-sphenoidal hypophysectomy. Q J Med1975;44:79–98.

    Google Scholar 

  45. McGuffin WL Jr, Sherman BM, Roth F, Gorden P, Kahn CR, Roberts WC, Frommer PL. Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med 1974;81: 11–18.

    Google Scholar 

  46. Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocrine Rev 1994;15:555–573.

    Google Scholar 

  47. Lie JT. Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients. Am Heart J 1980;100: 41–52.

    Google Scholar 

  48. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Nicolai E, Colao A, Biondi B, Lombardi G, Sacca L. Im-paired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994;79: 441–446.

    Google Scholar 

  49. Lopez-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL, Garcia-Robles R. Cardiac involvement in acromegaly: Specific myocardiopathy or conse-quence of systemic hypertension? J Clin Endocrinol Metab 1997;82:1047–1053.

    Google Scholar 

  50. Lie JT, Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980;100:41–52.

  51. Pinzone JJ, Katznelson L, Klibansky A. Acromegalic heart disease. The Endocrinologist 1998;8:273–278.

    Google Scholar 

  52. Hradec J, Marek J, Kral J, Janota T, Poloniecki J, Malik M. Long term echocardiographic follow-up of acromegalic heart disease. Am J Cardiol 1993;72:205–210.

    Google Scholar 

  53. Lombardi G, Colao A, Marzullo P, Ferone D, Lonobardi S, Esposito V, Merola B. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997;155:S33-S37.

    Google Scholar 

  54. Lim MJ, Barkan AL, Buda AJ. Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med 1992; 117:719–726.

    Google Scholar 

  55. Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J 1992;13:51–56.

    Google Scholar 

  56. Cuocolo A, Nicolai E, Fazio S, Pace L, Maurea S, Cittadini A, Sacca L, Salvatore M. Impaired left ventricular diastolic filling in patients with acromegaly: Assessment with radionuclide angiography. J Nucl Med 1995;36:196–201.

    Google Scholar 

  57. Oscarsson J, Wiklund O, Jakobsson KE, Petruson B, Bengtsson BA. Serum lipoproteins in acromegaly before and 6–15 months after transsphenoidal adenomectomy. Clin Endocrinol (Oxf) 1994;41:603–608.

    Google Scholar 

  58. Cohen R, Chanson P, Bruckert E, Timsit J, Legrand A, Harris AG, Guillausseau PJ, Warnet A, Lubetzki J. Effects of octreotide on lipid metabolism in acromegaly. Horm Metab Res 1992;24:397–400.

    Google Scholar 

  59. Tsuchiya H, Onishi T, Mogami H, Iida M. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy. Endocrinol Jpn 1990;37:797–807.

    Google Scholar 

  60. Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J. Basal-and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 1992;74:1012–1019.

    Google Scholar 

  61. Takeda R, Tatami R, Ueda K, Sagara H, Nakabayashi H, Mabuchi H. The incidence and pathogenesis of hyperlipidaemia in 16 consecutive patients. Acta Endocrinol (Copenh) 1982;100:358–362.

    Google Scholar 

  62. Parikh M, Iyeb K, Elias AN, Gwinup G. Spinal stenosis in acromegaly. Spine 1987;12:627–628.

    Google Scholar 

  63. Epstein N, Whelan M, Benjamin V. Acromegaly and spinal stenosis. Case report. J Neurosurg 1982;56:145–147.

    Google Scholar 

  64. Detenbeck LC, Tressler HA, O'Duffy JD, Randall RV. Peripheral joint manifestations of acromegaly. Clin Orthop 1973;91:119–127.

    Google Scholar 

  65. Podgorski M, Robinson B, Weissberger A, Stiel J, Wang S, Brooks PM. Particular manifestations of acromegaly. Aust NZ J Med 1988;18:28–35.

    Google Scholar 

  66. Bagge E, Eden S, Rosen T, Bengtsson B. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. Acta Endocrinologica 1993; 129:296–300.

    Google Scholar 

  67. Helal B. Acromegaly and its orthopaedic manifestations. Z Gesamte Inn Med 1983;38:395–398.

    Google Scholar 

  68. Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH. Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum 1988;31:1022–1027.

    Google Scholar 

  69. Kellgren JH, Ball J, Tutton GK. The articular and other limb changes in acromegaly. Q J Med1952;21:405–424.

    Google Scholar 

  70. Newman B, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Steward WN, Klibanski A, Molitch ME, Gagel RF, Boyd SE, Sheeler L, Cook D, Malarkey WB, Jackson I, Vance ML, Thorner MO, Ho PJ, Jaffe CA, Frohman LA, Kleinberg DL. Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients-a clinical research centre study. J Clin Endocrinol Metab 1995;80:2768–2775.

    Google Scholar 

  71. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P. Arthropathy in acromegalic patients before and after treat-ment: A long-term follow-up study. Clin Endocrinol (Oxf) 1988;28:515–524.

    Google Scholar 

  72. Le Roith D. Insulin-like growth factors. New Engl J Med 1997;336:633–640.

    Google Scholar 

  73. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393–1396.

    Google Scholar 

  74. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens H, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998;279:563–566.

    Google Scholar 

  75. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF. Acromegaly and gastrointestinal cancer. Cancer 1991;68: 1673–1677.

    Google Scholar 

  76. Barzilay J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991;151:1629–1632.

    Google Scholar 

  77. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980;12:71–79.

    Google Scholar 

  78. Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327–335.

    Google Scholar 

  79. Orme SM, Mcnally RJQ, Cartwright RA, Belchetz PE. Mor-tality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab 1998;83:2730–2734.

    Google Scholar 

  80. Vasen HF, van Erpecum KJ, Roelfsema F, Raue F, Koppeschaar H, Griffioen G, van Berge-Henegouwen GP. In-creased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol 1994;131:235–237.

    Google Scholar 

  81. Ortego J, Vega B, Sampedro J, Escalada J, Boixeda D, Varela C. Neoplastic colonic polyps in acromegaly. Horm Metab Res 1994;26:609–610.

    Google Scholar 

  82. Cheung NW, Boyages SC. Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol (Oxf) 1997; 47:323–327.

    Google Scholar 

  83. O'Sullivan AJ, Kelly JJ, Hoffman DM, Baxter RC, Ho KK. Energy metabolism and substrate oxidation in acromegaly. J Clin Endocrinol Metab 1995;80:486–491.

    Google Scholar 

  84. Davidoff LM. Studies in acromegaly III. The anamnesis and symptomatology in one hundred cases. Endocrinology 1926; 10:461–483.

    Google Scholar 

  85. Lawrence JH, Tobias CA, Linfoot JA, Born JL, Lyman JT, Chong CY, Manougian E, Wei WC. Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. J Clin Endocrinol Metab 1970;31:180–198.

    Google Scholar 

  86. Roelfsema F, Frolich M. Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transphenoidal surgery. Clin Endocrinol (Oxf) 1985;22:531–537.

    Google Scholar 

  87. Feek CM, Bevan JS, Taylor S, Brown NS, Baird JD. The effect of bromocryptine on insulin secretion and glucose tolerance in patients with acromegaly. Clin Endocrinol (Oxf) 1981;15:473–478.

    Google Scholar 

  88. Grunstein RR, Ho KY, Sullivan CE. Sleep apnoea in acromegaly. Ann Intern Med 1991;115:527–532.

    Google Scholar 

  89. Cardieux R, Kales A, Santen R, Bixler E, Godon R. En-doscopic findings in sleep apnoea associated with acromegaly. J Clin Endocrinol Metab 1980;55:18–22.

    Google Scholar 

  90. Piper JG, Dirks BA, Traynelis VC, VanGilder JC. Periopera-tive management and surgical outcome of the acromegalic patient with sleep apnoea. Neurosurgery 1995;36:70–75.

    Google Scholar 

  91. Grunstein RR, Ho KKY, Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnoea in patients with acromegaly. Ann Intern Med 1994;121:478–483.

    Google Scholar 

  92. Buyse B, Michiels E, Bouillon R, Bobbaers H, Demedts M. Relief of sleep apnoea after treatment of acromegaly: Report of three cases and review of the literature. Eur Respir J 1997;10:1401–1404.

    Google Scholar 

  93. Wrightson P, Rajasoorya C, Holdaway IM, Scott DJ. Acromegaly: Factors affecting the long term outcome after surgical treatment. J Clin Neuroscience 1994;1:164–172.

    Google Scholar 

  94. De Pablo F, Eastman RC, Roth J, Gorden P. Plasma prolactin in acromegaly before and after treatment. J Clin Endocrinol Metab 1981;53:344–352.

    Google Scholar 

  95. Smals AE, Pieters GF, Smals AG, Kloppenborg PW. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly. Acta Endocrinol (Copenh) 1988;117:387–391.

    Google Scholar 

  96. Van der Lely AJ, Harris AG, Lamberts SW. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: Influence of age and sex. Clin Endocrinol (Oxf) 1992;37:181–185.

    Google Scholar 

  97. Dons RF, Rieth KG, Gorden P, Roth J. Size and erosive features of the sella turcica in acromegaly as predictors of therapeutic response to supervoltage irradiation. Am J Med 1983;74:69–72.

    Google Scholar 

  98. Thapar K, Kovacs K, Laws ER, Muller PJ.Pituitary adenomas: Current concepts in classification, histopathology, and molecular biology. The Endocrinologist 1993;3:39–57.

    Google Scholar 

  99. Barkan AL. Acromegaly. Diagnosis and treatment. Endocrinol Metab Clin North Am 1989;18:277–310.

    Google Scholar 

  100. Abs R, Verhelst J, Maiter D, Van Acker K, Nobels F, Coolens JL, Mahler C, Beckers A. Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab 1998;83:374–378.

    Google Scholar 

  101. Melmed S. Molecular pathophysiology of acromegaly. Acta Paediatr 1996;417(Suppl):45–48.

    Google Scholar 

  102. Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bas-setti M, Faglia G. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 1990;71: 1421–1426.

    Google Scholar 

  103. Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR. Clinical characteristics of acromegalic patients whose pituitary tumours contain mutant Gs protein. J Clin Endocrinol Metab 1990;71:1416–1420.

    Google Scholar 

  104. Adams EF, Brockmeier S, Friedmann E, Roth M, Buchfelder M, Fahlbusch R. Clinical and biochemical charac-teristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors Neurosurgery 1993;33: 198–203.

    Google Scholar 

  105. Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A, Jaquet P. Prognostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. J Clin Endocrinol Metab 1998; 83:1604–1610.

    Google Scholar 

  106. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. Re-cent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395–3402.

    Google Scholar 

  107. Zhang X, Horwitz GA, Heaney AP, Prezant TR, Bronstein MD, Melmed S. Human pituitary tumor transforming gene (PTTG): Structure, function, and expression in pituitary tumors. Abstracts of the 80 th Annual Scientific Meeting, U.S. Endocrine Society, 1998;102.

  108. McCarthy MI, Noonan K, Wass JA, Monson JP. Familial acromegaly: Studies in three families. Clin Endocrinol (Oxf) 1990;32:719–728.

    Google Scholar 

  109. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Somatotrophinomas in multiple endocrine neoplasia type 1: A review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred. Am J Med 1996;100:544–547.

    Google Scholar 

  110. Losa M, von-Werder K. Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol (Oxf) 1997;47:123–135.

    Google Scholar 

  111. Barkan AL, Shenker Y, Grekin RJ, Vale WW, Lloyd RV, Beals TF. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: Dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab 1986;63:1057–1064.

    Google Scholar 

  112. Sano T, Asa SK, Kovacs K. GHRH-producing tumors: Clinical, biochemical and morphological manifestations. Endocrinol Rev 1998;9:357–373.

    Google Scholar 

  113. Ezzat S, Asa SL, Stefaneanu L, Whittom R, Symth HS, Hor-vath E, Kovacs K, Frohman LA. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 1994;78:555–560.

    Google Scholar 

  114. Genka S, Soeda H, Takahashi M, Katakami H, Sanno N, Osamura Y, Fuchinoue T, Teramoto A. Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Case report. J Neurosurg 1995;83:719–723.

    Google Scholar 

  115. Ezzat S, Ezrin C, Yamashita S, Melmed S. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor. Cancer 1993; 71:66–70.

    Google Scholar 

  116. Melmed S, Ezrin C, Kovacs K, Goodman RS, Frohman LA. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. New Engl J Med 1985;312: 9–17.

    Google Scholar 

  117. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 97:699–705.

  118. Lipson A, Hsu TH. The Albright syndrome associated with acromegaly: Report of a case and review of the literature. Johns Hopkins Med J 1981;149:10–14.

    Google Scholar 

  119. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: Clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994;131: 229–234.

    Google Scholar 

  120. Cuttler L, Jackson JA, Saeed-uz-Zafar M, Levitsky LL, Mellinger RC, Frohman LA. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 1989;68:1148–1154.

    Google Scholar 

  121. Yamada S, Sano T, Stefaneanu L, Kovacs K, Aiba T, Sawano S, Shishiba Y. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. 1993;76:352–356.

    Google Scholar 

  122. Stewart PM, Carey MP, Graham CT, Wright AD, London DR. Growth hormone secreting pituitary carcinoma: A case report and literature review. Clin Endocrinol (Oxf) 1992;37:189–194.

    Google Scholar 

  123. Clayton RN. New developments in the management of acromegaly. Should we achieve absolute biochemical cure? J Endocrinol 1997;155:S23-S29.

    Google Scholar 

  124. Holdaway IM, Rajasoorya C, Wong J, Orr-Walker B, Gamble G. The natural history of treated functional pituitary adenomas. In Webb S, ed. The Management of Pituitary Tumours. Bristol: BioScientifica Ltd, 1998:31–42.

    Google Scholar 

  125. Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA. Transsphenoidal adenomectomy for growth hormone-secreting adenomas in acromegaly: Outcome analysis and determinants of failure. J Neurosurg 1993;86:293–299.

    Google Scholar 

  126. Jenkins D, O'Brien I, Johnson A, Shakespear R, Sheppard MC, Stewart PM. The Birmingham pituitary database: Auditing the outcome of treatment of acromegaly. Clin Endocrinol 1995;43:517–522.

    Google Scholar 

  127. Rosen T, Bengtsson B. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285–288.

    Google Scholar 

  128. Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T, Hadden DR. Acertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J 1990;59:55–62.

    Google Scholar 

  129. Ross DA, Wilson CB. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. J Neurosurg 1988;68:854–867.

    Google Scholar 

  130. Davis DH, Laws ER, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BM, Root LM, Schleck C. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993;79:70–75.

    Google Scholar 

  131. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 1996;45:407–413.

    Google Scholar 

  132. Jamal GA, Kerr DJ, McLellan AR, Weir AI, Davies DL. Generalised peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological tech-niques. J Neurol Neurosurg Psych 1987;50:886–894.

    Google Scholar 

  133. Ibbertson HK, Manning PJ, Holdaway IM, Gamble G, Synek BJL. The acromegalic rosary. Lancet 1991;337:154–156.

    Google Scholar 

  134. Abed RT, Clark J, Elbadawy MH, Cliffe MJ. Psychiatric mor-bidity in acromegaly. Acta Psychiatr Scand 1987;75:635–639.

    Google Scholar 

  135. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 1993;76:1452–1457.

    Google Scholar 

  136. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf) 1998;48:59–65.

    Google Scholar 

  137. Grisoli E, Leclercq T, Jaquet P, Guibout M, Winteler JP, Hassoun J, Vincentelli F. Transsphenoidal surgery for acromegaly-Long-term results in 100 patients. Surg Neurol 1985;23:513–519.

    Google Scholar 

  138. Losa M, Oeckler R, Schopohl J, Muller OA, Alba-Lopez J, von Werder K. Evaluation of selective transsphenoidal ade-nomectomy by endocrinological testing and somatomedin-C measurements in acromegaly. J Neurosurg 1989;70:561–567.

    Google Scholar 

  139. Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P. Factors determining the long-term outcome of surgery for acromegaly. Q J Med1994;87:617–623.

    Google Scholar 

  140. Nye ER, Paulin J, Russell DG. Blood pressure in a random sample of the New Zealand population. N Z Med J 1992;105:1–3.

    Google Scholar 

  141. Simmons D, Gatland B, Fleming C, Laekehe L, Scragg R. Prevalence of known diabetes in a multiethnic community. N ZMed J1994;107:219–222.

    Google Scholar 

  142. Lawrence RC, Hoohberg MC, Kelsey JL, McDuffie FC, Medsger TA, Felts WR, Shulman LE. Estimates of the prevalence of selected arthritic and musculoskeletal dis-eases in the United States. J Rheumatol 1989;16:427–441.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Auckland Hospital, Auckland, New Zealand

    I. M. Holdaway

  2. Department of Medicine, Alexandra Hospital, Singapore

    C. Rajasoorya

Authors
  1. I. M. Holdaway
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Rajasoorya
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holdaway, I.M., Rajasoorya, C. Epidemiology of Acromegaly. Pituitary 2, 29–41 (1999). https://doi.org/10.1023/A:1009965803750

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009965803750

Keywords

Search

Navigation